Related by context. Frequent words. (Click for all words.) 64 Presents Positive 64 Files Shelf Registration Statement 64 Completes Enrollment 63 Develop Novel 62 Q3 Loss Narrows 62 Announce Collaboration 62 Movers Roundup 62 Inc Therapeutic Competitors 62 Q3 Loss Widens 61 Completes Tender Offer 61 Q2 Loss Narrows 61 Q1 Loss Narrows 61 Director Exercises Options 60 Q2 Loss Widens 60 Q4 Loss Narrows 60 Announces Initiation 60 CEO Exercises Options 60 Stockholders Approve Merger 60 Bearish Pressure Building 59 Q4 Loss Widens 59 Finalizes Acquisition 59 Nasdaq BIIB 59 FDA Clears 59 Earnings Scorecard 59 Announces Definitive Agreement 59 Q2 Profit Surges 59 Conference Call TRANSCRIPT 59 Q1 Loss Widens 59 Announces Presentation 59 Guides Below 58 PROFILE CO 58 Closes Acquisition Of 58 Announces Additions 58 Explore Strategic Alternatives 58 Announces Organizational Changes 58 Secures Financing 58 Exploit collaboration 58 CEO Discusses Q1 58 quotes/comstock/# * 58 Idera Pharmaceuticals 58 PRODUCT SOURCE 58 Q4 Profit Surges 58 Nasdaq AMGN 57 Initiates Phase 57 Small Molecule 57 Inc. Nasdaq IMGN 57 OSIR 57 CFO Resigns 57 Net Loss Narrows 56 www.schering plough.com 56 Posts Wider Loss 56 Lowers Guidance 56 Guides Above 56 Drug Candidate 56 Regains Compliance With 55 Q3 Profit Surges 55 Celebrates Opening 55 Patent Covering 55 Skymark Research Initiates Independent 55 Calls Purchased 55 Lexicon Pharmaceuticals 55 R sorafenib tablets 55 Shares Changing Hands 55 Merrimack Pharmaceuticals 55 Transcept Pharmaceuticals 55 ENZN 55 NV Organon 55 Secures Additional 54 Options Brief 54 ICOS Corporation 54 RNAi Therapeutics 54 AVEO Pharmaceuticals 54 Discusses Q3 54 Holds Annual Meeting 54 QLTI 54 Inc. NASDAQ TRGT 54 ALNY 54 Inc. Nasdaq SEPR 54 CRXX 54 Rule Breakers recommendation 54 4Q Profit Jumps 53 VRUS 53 Inc. F#Q# Qtr 53 Copegus R 53 Webcast Annual Meeting 53 Regeneron Pharmaceuticals 53 Lexicon Genetics 53 Vicuron Pharmaceuticals 53 Options Trader Alert 53 DVAX 53 Small Molecules 53 INCY 53 Analyst Actions 53 Guides FY# Quick Facts 53 Archemix Corp. 53 Idenix Pharmaceuticals 53 FDA Accepts 53 EPIX Pharmaceuticals Inc. 53 Files Annual Report 53 PHARM 53 Indevus Pharmaceuticals